Aggarwal Sumit has filed 24 insider transactions across 1 company since February 2022.
Most recent transaction: a option exercise of 260946 shares of Eloxx Pharmaceuticals, Inc. ($ELOX) on February 28, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2026 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | M | Stock Option (Right to Buy) | 260946 | $0.00 | 3,336,144.0000 | 12,347,495 | 7.25% | 2.11% |
| Aug. 14, 2025 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 3,758,804 | 100.00% | 0.67% |
| Aug. 14, 2025 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | M | Stock Option (Right to Buy) | 42790 | $0.00 | 0.0000 | 3,758,804 | 100.00% | 1.14% |
| Sept. 19, 2025 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | A | Stock Option (Right to Buy) | 3597090 | $0.00 | 3,597,090.0000 | 3,758,804 | 9999.99% | 95.70% |
| Jan. 24, 2026 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | M | Restricted Stock Units | 15000 | $0.00 | 15,000.0000 | 12,347,495 | 50.00% | 0.12% |
| Aug. 14, 2025 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | M | Common Stock | 196880 | $0.00 | 396,810.0000 | 3,758,804 | 98.47% | 5.24% |
| Sept. 19, 2025 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | A | Common Stock | 1000000 | $0.00 | 1,396,810.0000 | 3,758,804 | 252.01% | 26.60% |
| Jan. 24, 2026 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | M | Common Stock | 15000 | $0.00 | 1,411,810.0000 | 12,347,495 | 1.07% | 0.12% |
| Feb. 28, 2026 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | M | Common Stock | 260946 | $0.15 | 1,672,756.0000 | 12,347,495 | 18.48% | 2.11% |
| Feb. 6, 2022 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | A | Stock Option (Right to Buy) | 42790 | $0.00 | 42,790.0000 | 1,749,071 | 9999.99% | 2.45% |
| Oct. 16, 2024 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | D | Stock Option (Right to Buy) | 42790 | $0.00 | 0.0000 | 2,570,620 | 100.00% | 1.66% |
| Oct. 16, 2024 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | A | Stock Option (Right to Buy) | 42790 | $0.00 | 42,790.0000 | 2,570,620 | 9999.99% | 1.66% |
| Oct. 16, 2024 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | D | Stock Option (Right to Buy) | 35580 | $0.00 | 0.0000 | 2,570,620 | 100.00% | 1.38% |
| Oct. 16, 2024 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | A | Stock Option (Right to Buy) | 35580 | $0.00 | 35,580.0000 | 2,570,620 | 9999.99% | 1.38% |
| Oct. 16, 2024 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | D | Stock Option (Right to Buy) | 24810 | $0.00 | 0.0000 | 2,570,620 | 100.00% | 0.97% |
| Oct. 16, 2024 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | A | Stock Option (Right to Buy) | 24810 | $0.00 | 24,810.0000 | 2,570,620 | 9999.99% | 0.97% |
| Oct. 16, 2024 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | D | Stock Option (Right to Buy) | 68700 | $0.00 | 0.0000 | 2,570,620 | 100.00% | 2.67% |
| Oct. 16, 2024 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | A | Stock Option (Right to Buy) | 68700 | $0.00 | 68,700.0000 | 2,570,620 | 9999.99% | 2.67% |
| Aug. 14, 2025 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | M | Stock Option (Right to Buy) | 60390 | $0.00 | 0.0000 | 3,758,804 | 100.00% | 1.61% |
| Aug. 14, 2025 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | President and CEO | M | Stock Option (Right to Buy) | 68700 | $0.00 | 0.0000 | 3,758,804 | 100.00% | 1.83% |
| Jan. 24, 2025 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | Director | M | Restricted Stock Units | 30000 | $0.00 | 30,000.0000 | 3,758,804 | 50.00% | 0.80% |
| Jan. 24, 2025 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | Director | M | Common Stock | 30000 | $0.00 | 199,930.0000 | 3,758,804 | 17.65% | 0.80% |
| Oct. 16, 2024 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | PRESIDENT AND CEO | A | Common Stock | 165000 | $0.00 | 169,930.0000 | 2,570,620 | 3346.86% | 6.42% |
| Jan. 24, 2024 | Eloxx Pharmaceuticals, Inc. | $ELOX | Aggarwal Sumit | PRESIDENT AND CEO | A | Restricted Stock Units | 60000 | $0.00 | 60,000.0000 | 2,570,620 | 9999.99% | 2.33% |